Market Place
Sourcing Support
Solid Bio Reports Inducement Grants Under Nasdaq LR5635(c)(4)
04 Nov 2024 //
GLOBENEWSWIRE
Solid Bio to Present at Truist Securities BioPharma Symposium
31 Oct 2024 //
GLOBENEWSWIRE
Solid Bio Reports Inducement Grants Under Nasdaq LR 5635(c)(4)
03 Oct 2024 //
GLOBENEWSWIRE
Solid Biosciences Inducement Grants Under Nasdaq Rule 5635(c)(4)
02 Oct 2024 //
GLOBENEWSWIRE
Solid Bio To Attend Chardan Genetic Medicines Conference
23 Sep 2024 //
GLOBENEWSWIRE
Solid Biosciences to Participate at the 2024 Cantor Global Healthcare Conference
12 Sep 2024 //
GLOBENEWSWIRE
Solid Biosciences to Participate at Upcoming Investor Conferences
04 Sep 2024 //
GLOBENEWSWIRE
Solid Biosciences Reports Inducement Grants Under Nasdaq Rule
04 Sep 2024 //
GLOBENEWSWIRE
Solid Biosciences Reports Q2 2024 Results And Business Updates
13 Aug 2024 //
GLOBENEWSWIRE
Solid Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
05 Aug 2024 //
GLOBENEWSWIRE
Solid Biosciences Joins the Russell 3000® Index
01 Jul 2024 //
GLOBENEWSWIRE
Solid Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
01 Jul 2024 //
GLOBENEWSWIRE
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 Jun 2024 //
GLOBENEWSWIRE
Solid Biosciences Provides Q1 2024 Business Update, Financials
15 May 2024 //
GLOBENEWSWIRE
Solid Biosciences To Present At ASGCT Annual Meeting
07 May 2024 //
GLOBENEWSWIRE
AAV Manufacturing Takes Center Stage at ASGCT24
07 May 2024 //
BIOSPACE
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 May 2024 //
GLOBENEWSWIRE
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 Apr 2024 //
GLOBENEWSWIRE
Solid Bio Receives Rare Pediatric Disease Designation from the FDA for DMD
01 Apr 2024 //
GLOBENEWSWIRE
Solid to Participate at Cantor`s Virtual Muscular Dystrophy Symposium
27 Mar 2024 //
GLOBENEWSWIRE
Solid Biosciences Provides Fourth Quarter and Full-Year 2023 Financial Results
13 Mar 2024 //
GLOBENEWSWIRE
Solid Biosciences Announces Licensing Agreement with Armatus Bio
07 Mar 2024 //
GLOBENEWSWIRE
Solid Biosciences to Participate at Upcoming Investor Conferences
06 Mar 2024 //
GLOBENEWSWIRE
Solid Biosciences Granted FDA Orphan Drug Designation for SGT-003
16 Jan 2024 //
GLOBENEWSWIRE
Solid Biosciences Announces $109 Million Private Placement
08 Jan 2024 //
GLOBENEWSWIRE
Solid Bio to Participate at 42nd Annual J.P. Morgan Healthcare Conference
04 Jan 2024 //
GLOBENEWSWIRE
Solid Biosciences Receives FDA Fast Track Designation for SGT-003
07 Dec 2023 //
GLOBENEWSWIRE
Solid Bio to Participate at 35th Annual Piper Sandler Healthcare Conference
22 Nov 2023 //
GLOBENEWSWIRE
Solid Biosciences Announces IND Clearance by FDA for SGT-003
14 Nov 2023 //
GLOBENEWSWIRE
Solid Biosciences to Participate at Jefferies London Healthcare Conference
09 Nov 2023 //
GLOBENEWSWIRE
Solid Biosciences Provides Third Quarter Business Update and Financial Results
08 Nov 2023 //
GLOBENEWSWIRE
Solid Biosciences Appoints Gabriel Brooks, M.D., as Chief Medical Officer
02 Oct 2023 //
GLOBENEWSWIRE
Solid Biosciences to Participate at Upcoming Investor Conferences
20 Sep 2023 //
GLOBENEWSWIRE
Solid Biosciences to Participate at Upcoming Investor Conferences
05 Sep 2023 //
GLOBENEWSWIRE
Solid Biosciences to Participate in Citis 18th Annual BioPharma Conference
31 Aug 2023 //
GLOBENEWSWIRE
Solid Biosciences Provides Second Quarter Business Update and Financial Results
14 Aug 2023 //
GLOBENEWSWIRE
DOJ accuses billionaire of insider trading in Solid Bio, Mirati
26 Jul 2023 //
FIERCE BIOTECH
Solid Biosciences to Participate at the Jefferies Healthcare Conference
01 Jun 2023 //
GLOBENEWSWIRE
Solid Biosciences to Participate at the Barclays Gene Editing & Therapy Summit
22 May 2023 //
GLOBENEWSWIRE
Solid Biosciences to Present at the American Society of Gene and Cell Therapy
16 May 2023 //
GLOBENEWSWIRE
Solid Biosciences Provides First Quarter Business Update and Financial Results
11 May 2023 //
GLOBENEWSWIRE
Solid Biosciences to Present at JMP Securities Life Sciences Conference
08 May 2023 //
GLOBENEWSWIRE
Solid Biosciences to Participate in Chardanâ™s 7th Annual Genetic Medicines
21 Apr 2023 //
GLOBENEWSWIRE
Solid Biosciences to Present at the 22nd Annual Needham Healthcare Conference
13 Apr 2023 //
GLOBENEWSWIRE
Solid Biosciences Provides 4Q and Full Year 2022 Financial Results
23 Mar 2023 //
GLOBENEWSWIRE
Solid Biosciences to Participate at BMO Biopharma Spotlight Series
21 Mar 2023 //
GLOBENEWSWIRE
Solid Biosciences to Present at Barclays Global Healthcare Conference
07 Mar 2023 //
GLOBENEWSWIRE
Solid Biosciences to Present at SVB Securities Global Biopharma Conference
08 Feb 2023 //
GLOBENEWSWIRE
Solid Bio Outlines Strategy for Leadership in Precision Genetic Medicines
10 Jan 2023 //
GLOBENEWSWIRE
Inspire Medical Announces Preliminary Results for Q4 and Full Year 2022
09 Jan 2023 //
GLOBENEWSWIRE
Solid Biosciences Appoints Kevin Tan, CFA, as Chief Financial Officer
09 Jan 2023 //
GLOBENEWSWIRE
Solid Biosciences Reports Inducement Grant to CFO and Treasurer
09 Jan 2023 //
GLOBENEWSWIRE
Solid Biosciences Announces Closing of Acquisition AavantiBio &Concurrent $75 M
05 Dec 2022 //
GLOBENEWSWIRE
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 Dec 2022 //
GLOBENEWSWIRE
Solid Biosciences Announces Stockholder Approval of Acquisition of AavantiBio
02 Dec 2022 //
GLOBENEWSWIRE
Solid Biosciences to Participate at Piper Sandler Annual Healthcare Conference
22 Nov 2022 //
GLOBENEWSWIRE
Solid Biosciences Reports Preclinical Data Demonstrating-Novel Capsid,AAV-SLB101
17 Oct 2022 //
GLOBENEWSWIRE
Solid Biosciences Presents New SGT-001 IGNITE DMD Study Results
13 Oct 2022 //
GLOBENEWSWIRE
Solid Bio yields to Sarepta on Duchenne with plans for merger, R&D shakeup
01 Oct 2022 //
BIOPHARMADIVE
Solid Biosciences to Participate at Upcoming Investor Conferences
29 Sep 2022 //
GLOBENEWSWIRE
